Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053873169> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2053873169 endingPage "243" @default.
- W2053873169 startingPage "229" @default.
- W2053873169 abstract "Chronic Obstructive Pulmonary Disease (COPD) is a complex genetic disease in which multiple susceptibility genes and environmental factors interact to contribute to its development. Although there are two major approaches that can be used to identify susceptibility genes i.e. association studies and genomic scans, most of our knowledge of COPD genetics is derived from association studies. We review association studies of COPD that have examined genes involved in protease-antiprotease and oxidant-antioxidant balance, inflammation and airway defense. Currently, there are four major therapeutic approaches available: 1) Smoking cessation is the most important intervention to alter the clinical course, but only small proportion of smokers are able to quit successfully. Knowledge of genetic susceptibility may increase the rate of smoking cessation; 2) Therapy with bronchodilators; 3) Therapy with corticosteroids. The latter two approaches are the mainstay of current therapy. It has been shown that β2-adrenergic receptor (β2AR) gene polymorphisms affect β2-agonist therapy. However, no polymorphisms have been discovered that affect treatment with anticholinergics, theophylline or corticosteroids; 4) α1-antitrypsin (α1AT) replacement therapy is moderately effective in patients with α1-AT deficiency. New therapeutic methods based on knowledge of COPD genetics are urgently needed since current therapy has not been shown to prevent progression of COPD. Such methods may include protease inhibitors, mediator inhibitors and new anti-inflammatory agents. Thus, knowledge of COPD pharmacogenomics may help to tailor the most appropriate treatment for an individual patient. Keywords: copd, genetics, polymorphisms, candidate gene, association study, genomic scan, pharmacogenomics, smoking cessation, alpha-1-antitrypsin, agonist" @default.
- W2053873169 created "2016-06-24" @default.
- W2053873169 creator A5026022017 @default.
- W2053873169 creator A5030904243 @default.
- W2053873169 date "2003-12-01" @default.
- W2053873169 modified "2023-10-14" @default.
- W2053873169 title "Pharmacogenomics of COPD" @default.
- W2053873169 doi "https://doi.org/10.2174/1570160033476223" @default.
- W2053873169 hasPublicationYear "2003" @default.
- W2053873169 type Work @default.
- W2053873169 sameAs 2053873169 @default.
- W2053873169 citedByCount "1" @default.
- W2053873169 crossrefType "journal-article" @default.
- W2053873169 hasAuthorship W2053873169A5026022017 @default.
- W2053873169 hasAuthorship W2053873169A5030904243 @default.
- W2053873169 hasConcept C104317684 @default.
- W2053873169 hasConcept C126322002 @default.
- W2053873169 hasConcept C135763542 @default.
- W2053873169 hasConcept C142724271 @default.
- W2053873169 hasConcept C170734499 @default.
- W2053873169 hasConcept C2776042228 @default.
- W2053873169 hasConcept C2776780178 @default.
- W2053873169 hasConcept C2777843972 @default.
- W2053873169 hasConcept C2779134260 @default.
- W2053873169 hasConcept C54355233 @default.
- W2053873169 hasConcept C55775858 @default.
- W2053873169 hasConcept C60644358 @default.
- W2053873169 hasConcept C71924100 @default.
- W2053873169 hasConcept C86803240 @default.
- W2053873169 hasConcept C98274493 @default.
- W2053873169 hasConceptScore W2053873169C104317684 @default.
- W2053873169 hasConceptScore W2053873169C126322002 @default.
- W2053873169 hasConceptScore W2053873169C135763542 @default.
- W2053873169 hasConceptScore W2053873169C142724271 @default.
- W2053873169 hasConceptScore W2053873169C170734499 @default.
- W2053873169 hasConceptScore W2053873169C2776042228 @default.
- W2053873169 hasConceptScore W2053873169C2776780178 @default.
- W2053873169 hasConceptScore W2053873169C2777843972 @default.
- W2053873169 hasConceptScore W2053873169C2779134260 @default.
- W2053873169 hasConceptScore W2053873169C54355233 @default.
- W2053873169 hasConceptScore W2053873169C55775858 @default.
- W2053873169 hasConceptScore W2053873169C60644358 @default.
- W2053873169 hasConceptScore W2053873169C71924100 @default.
- W2053873169 hasConceptScore W2053873169C86803240 @default.
- W2053873169 hasConceptScore W2053873169C98274493 @default.
- W2053873169 hasIssue "4" @default.
- W2053873169 hasLocation W20538731691 @default.
- W2053873169 hasOpenAccess W2053873169 @default.
- W2053873169 hasPrimaryLocation W20538731691 @default.
- W2053873169 hasRelatedWork W1987948216 @default.
- W2053873169 hasRelatedWork W2062242928 @default.
- W2053873169 hasRelatedWork W2094261348 @default.
- W2053873169 hasRelatedWork W2350943432 @default.
- W2053873169 hasRelatedWork W2521506406 @default.
- W2053873169 hasRelatedWork W2623123140 @default.
- W2053873169 hasRelatedWork W2753240051 @default.
- W2053873169 hasRelatedWork W3030102980 @default.
- W2053873169 hasRelatedWork W4285265853 @default.
- W2053873169 hasRelatedWork W4320084451 @default.
- W2053873169 hasVolume "1" @default.
- W2053873169 isParatext "false" @default.
- W2053873169 isRetracted "false" @default.
- W2053873169 magId "2053873169" @default.
- W2053873169 workType "article" @default.